Published on 08/12/2025

EPCIS Upgrades: 1.2→2.0—Evidence Expectations

The evolution of the Electronic Product Code Information Services (EPCIS) from version 1.2 to 2.0 presents significant implications for the pharmaceutical industry, particularly concerning serialization and data integrity. As regulatory bodies such as the FDA, EMA, and MHRA intensify their focus on compliance with data integrity standards, understanding the latest updates and expectations associated with EPCIS is crucial for pharmaceutical professionals. This tutorial provides a structured approach to navigating these upgrades, emphasizing testing methodologies and evidence expectations.

Understanding EPCIS Enhancements: Key Changes from 1.2 to 2.0

The transition from EPCIS 1.2 to 2.0 introduces pivotal enhancements aimed at enriching supply chain visibility and data interoperability. It is essential for professionals to dissect these changes thoroughly to ensure compliance with serialization and aggregation requirements.

Key Features of EPCIS 2.0

• Increased Data Integrity Capabilities: EPCIS 2.0 integrates enhanced standards for data quality, including compliance with the ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, and Complete).
• Support for Complex Supply Chains: It accommodates improved data architectures, enabling better tracking of aggregated product levels—from individual unit to case to pallet.
• Interoperability Improvements: The upgrade emphasizes seamless communication across different systems, ensuring that data sharing between partners complies with the latest regulatory mandates.

Understanding these features is foundational to implementing effective serialization change control initiatives, ensuring compliance with the Drug Supply Chain Security Act (DSCSA) in the US and the EU Falsified Medicines Directive (FMD) requirements.

Developing User Requirement Specifications (URS) for EPCIS 2.0

Creating comprehensive User Requirement Specifications (URS) is a crucial first step in the transition process. A well-formulated URS will guide the validation and compliance efforts tailored to the enhancements made in EPCIS 2.0.

Step-by-step Development of URS

1. Stakeholder Engagement: Begin by gathering input from all relevant stakeholders, including IT, operations, quality assurance, and regulatory affairs teams. Their insights are invaluable in identifying system requirements, functionality expectations, and compliance goals.
2. Define Functional Requirements: clearly outline the specific functionalities that the EPCIS system must possess, derived from both the EPCIS 2.0 specifications and organizational objectives. This should include capabilities related to serialization movements, data hierarchies, and aggregation processes.
3. Compliance Mapping: Align your URS with regulatory requirements pertinent to your operational regions (US, UK, EU). Identify the necessary data attributes and audit trails vital for compliance with DSCSA and EU FMD regulations.
4. Validation Testing Requirements: Specify how testing will be conducted, including the methods for unit testing, system integration testing, and user acceptance testing (UAT) that comply with industry standards.

By developing a thorough URS, organizations can ensure that they establish a clear foundation for their EPCIS upgrade project, paving the way for streamlined testing and validation processes.

Testing Methodologies: Controlled Testing for EPCIS 2.0

The evolution to EPCIS 2.0 necessitates rigorous testing processes to guarantee that all functionalities operate according to the established URS. Implementing controlled testing methodologies is crucial for achieving compliance and ensuring operational effectiveness.

Types of Testing to Implement

• Unit Testing: Verifies individual components for correctness and adherence to specifications. Conduct unit testing for software modules that report tiered data on serialization and aggregation.
• Integration Testing: Essential to ensuring that the new EPCIS system seamlessly interacts with existing solutions and platforms used in operations.
• User Acceptance Testing (UAT): Conduct UAT with end-users to validate that the system meets all functional requirements as defined in the URS.

Furthermore, organizations should incorporate testing into their validation strategy that reflects the reality of their operational environment, particularly accommodating conditions outlined in the EPCIS 2.0 updates.

Establishing Data Integrity through Reconciliation Rules

A critical component of serialization and aggregation processes involves implementing data integrity measures—particularly through reconciliation rules. As the pharmaceutical landscape grows more complex, establishing robust reconciliation processes ensures that discrepancies in data can be adequately identified and resolved.

Reconciliation Process Overview

1. Data Mapping: Establish a mapping of data inputs from multiple sources to ensure consistency and completeness.
2. Define Reconciliation Metrics: Develop specific metrics to identify correct data flows and pinpoint areas for review, such as mismatching serialization numbers.
3. Automate Exception Handling: Integrate automated systems for monitoring serialization transactions and exception identification to reduce manual intervention and increase efficiency.
4. Regular Audits: Conduct periodic audits not only for compliance but for ongoing verification of data accuracy across systems, aligning with regulatory expectations.

This comprehensive approach to reconciliation not only addresses regulatory requirements but significantly contributes to the overall efficacy of the serialization and aggregation program.

Exception Handling and Compliance Capabilities

Exception handling is intrinsic to maintaining a streamlined and compliant serialization process. EPCIS 2.0 emphasizes the need for efficient exception handling systems to manage issues arising from data discrepancies or system faults.

Implementing Robust Exception Management Practices

1. Identify Potential Exceptions: Work cross-functionally to identify common points of failure or data misalignment that could lead to exceptions within your EPCIS operation.
2. Define Exception Workflow: Establish a clear, documented workflow for managing exceptions, detailing the procedures to be followed when exceptions are encountered, including notifications and escalations.
3. Training and Awareness: Ensure personnel are well-versed in handling exceptions as per the defined process. Regular training sessions can reinforce protocols and improve compliance.
4. Review and Continuous Improvement: Routinely review exception case patterns and refine processes to reduce recurrence of similar issues, thus supporting a culture of continuous improvement.

Compliance with these exception handling practices not only fulfills regulatory obligations but also safeguards product integrity within the supply chain, thereby enhancing operational reliability.

Audit Trail Review and Change Control Mechanisms

Establishing a reliable audit trail and a robust change control mechanism is essential for maintaining compliance with both industry regulations and internal standards. The enhancements brought by EPCIS 2.0 necessitate stricter guidelines around change control and documentation practices.

Constructing an Effective Audit Trail

1. Document Changes: Every change introduced to the EPCIS system should be rigorously documented. This includes changes to data inputs, software updates, or modifications to processes.
2. Timestamp and Authorship: Ensure that every entry in the audit trail is timestamped and attributed to an accountable party, supporting the ALCOA+ principles of data integrity.
3. Regular Review of Audit Trails: Conduct scheduled reviews of audit trails to identify any inconsistencies or anomalies that may require deeper investigation.

Change control is equally critical in maintaining compliance with EPCIS 2.0 guidelines. Organizations must establish procedures to manage change systematically, requiring appropriate risk assessments and impact analyses prior to implementing any modifications in the serialization process.

Conclusion: Navigating EPCIS 2.0 Compliance and Evidence Expectations

The upgrade from EPCIS 1.2 to 2.0 presents new challenges and opportunities for professionals in the pharmaceutical industry. The alignment with regulatory standards is not just an obligation but a crucial element in sustaining trust and safety within supply chains. By following the structured approaches outlined in this tutorial—completing robust URS development, leveraging rigorous testing methodologies, and establishing strong data integrity and exception handling practices—organizations can facilitate a smoother transition to EPCIS compliance.

Professionals engaged in these processes must remain vigilant in understanding the evolving landscape of serialization, aggregation, and broader supply chain data integrity. Continued education and awareness of the regulatory frameworks and best practices will equip organizations to uphold the highest standards of compliance and operational excellence.